An LPN was observed handling morphine and another medication from the med cart without first checking the MAR, and she later acknowledged drawing up morphine from a leaking bottle and putting it back into the bottle. Shift-change narcotic documentation showed a wet morphine box and an entry for waste, but the time and amount wasted were not recorded, and the controlled substance audit process did not reconcile unit records with the pharmacy proof of use sheets.
The facility failed to ensure accurate reconciliation of controlled substances at shift change. Review of narcotics and sedatives count sheets for three units showed multiple missed documentation entries across two months, and the DON stated the licensed nurse was responsible for completing the count at every shift change. The Controlled Substance policy required counts at receipt, administration, disposition, and the end of each shift, with the oncoming and offgoing nurses counting together.
A resident with chronic pain and severe cognitive impairment did not receive an ordered Schedule II pain medication when the supply ran out and the order was later placed on hold because of an insurance preauthorization issue that the facility was unaware of. In addition, two residents had hydromorphone administrations recorded on the controlled substance log but not on the MAR by LPNs, and expired hydromorphone packs and records were still found in the locked med cart after the orders had ended.
A resident with anxiety, dermatitis, and hypothyroidism did not consistently receive ordered medications, including Levothyroxine, Xanax, and Dupixent, as documented on the MAR. Levothyroxine doses were missed on consecutive days, with one omission unexplained and another marked as not available despite prior delivery from the pharmacy, and no provider notification was documented. A scheduled Dupixent dose was delayed due to unavailability, and a Xanax dose was missed and marked as not available even though the medication had been received, again without documented provider notification. An APRN later noted the resident experienced intermittent seizure-like activity when the morning Xanax dose was missed and stated she should have been notified of omissions. Interviews with the DNS and LPNs revealed issues with agency staff marking medications as not available, failure to verify and obtain medications from stock or pharmacy, and lack of provider notification, contrary to facility medication administration and documentation policy.
A resident with seizure disorder, dementia, and multiple comorbidities experienced repeated failures in timely medication administration and documentation. Required scheduled doses of gabapentin and acetaminophen were not documented as given at the ordered time, despite an RN later stating they had been administered. On another day, an RN documented a set of 9:00 AM medications, including anticonvulsants, antihypertensives, anticoagulant, antidepressant, and laxative, more than four hours late, while another RN administered evening anticonvulsant, analgesic, muscle relaxant, anticoagulant, sleep aid, antidepressant, and neuropathy medications more than two to three hours earlier than scheduled. One RN reported routinely delaying electronic documentation until after completing the full med pass due to EMR issues and workload, contrary to the facility’s one-hour administration window and immediate documentation standard.
The facility failed to maintain proper control and accountability of discontinued narcotic medications, resulting in missing Oxycodone and Lorazepam tablets for three residents with pain, dementia, and anxiety. Discontinued controlled drugs remained in unit narcotic lock boxes instead of being promptly removed to a secured nursing office lock box, and both the white proof-of-use sheets and matching medication packs went missing. An LPN’s narcotic audits did not include MAR review, discrepancies were adjusted to match proof-of-use sheets, and required dual nurse signatures for end-of-shift narcotic counts were missing on multiple dates. These actions and omissions violated the facility’s own controlled substance handling policy and led to unaccounted-for controlled substances.
Lack of Controlled Medication Reconciliation Process: The facility failed to maintain a process for controlled med audits and reconciliation. The ADNS said bi-weekly audits were done by counting meds at the carts and matching white and yellow CSDRs later, but she did not bring the yellow CSDR binders to the audits and could not identify a policy for the process. Surveyors found yellow CSDRs dating back over time, 23 records flagged for reconciliation, and the facility leadership stated there was no policy directing the audits. The ADNS reconciled 22 records but could not account for Tramadol HCL 50 mg half tablets received earlier.
Missing Controlled Drug Count Signatures: The facility failed to ensure shift-to-shift controlled drug counts were consistently completed for a medication cart on the South unit. The controlled drugs count record was missing 4 signatures across 2 shifts, and the DNS stated she was unaware of the omissions until the review. The facility policy required the oncoming and offgoing nurses to count controlled drugs together and document any discrepancies.
Control drug reconciliation was not maintained. Review of the narcotic receipt/disposition records found multiple yellow sheets in the 2025 binder that were not matched to the white copies, including records for oxycodone, pregabalin, morphine, and lorazepam. Review of prior reconciled records also found remaining amounts of morphine solution and lorazepam tablets with no evidence of where the medication was located. The DNS said the process had been disorganized, had been delegated to other RNs, and that some white sheets may have gone home with residents or staff.
Failure to Reconcile Controlled Substances: The facility failed to consistently and accurately reconcile controlled substances for 2 medication carts. Monthly or bi-monthly audits could not be produced, and the DNS stated she had not completed any controlled substance reconciliations or audits since starting at the facility. The DNS said the process involved counting controlled substances and comparing them to the CSDR, but the facility could not verify the accuracy of its controlled substance inventory and did not provide a Controlled Substance Reconciliation and Audit policy.
Self-audit
Pick a level of detail and, optionally, what to focus on — then generate a survey-ready checklist distilled from the most recent citations.
Beta · AI-generated — for reference only, not professional advice. Verify against current CMS guidance before relying on it. Assisto accepts no responsibility for how this checklist is used.
Citations used to create this checklist
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.